Shanthakumar Wilson Rajaratnam, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Automobile Driving | 3 | 2015 | 431 | 0.830 |
Why?
|
| Circadian Rhythm | 8 | 2015 | 2624 | 0.730 |
Why?
|
| Work Schedule Tolerance | 4 | 2014 | 565 | 0.570 |
Why?
|
| Sleep Deprivation | 3 | 2015 | 832 | 0.530 |
Why?
|
| Safety | 3 | 2011 | 1186 | 0.520 |
Why?
|
| Accidents, Traffic | 2 | 2015 | 819 | 0.520 |
Why?
|
| Wakefulness | 2 | 2012 | 1245 | 0.490 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2012 | 222 | 0.380 |
Why?
|
| Police | 2 | 2011 | 149 | 0.380 |
Why?
|
| Indenes | 1 | 2010 | 57 | 0.360 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 603 | 0.350 |
Why?
|
| Melatonin | 4 | 2014 | 721 | 0.320 |
Why?
|
| Sleep | 5 | 2023 | 4623 | 0.300 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2023 | 1004 | 0.300 |
Why?
|
| Criminal Law | 1 | 2005 | 96 | 0.240 |
Why?
|
| Health Status | 1 | 2011 | 4034 | 0.160 |
Why?
|
| Fatigue | 1 | 2005 | 1531 | 0.150 |
Why?
|
| Actigraphy | 3 | 2023 | 488 | 0.150 |
Why?
|
| Polysomnography | 4 | 2014 | 1776 | 0.150 |
Why?
|
| Behavior Therapy | 1 | 2021 | 865 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2021 | 1125 | 0.120 |
Why?
|
| Occupational Health | 2 | 2011 | 809 | 0.120 |
Why?
|
| Rhinomanometry | 1 | 2013 | 8 | 0.110 |
Why?
|
| Eye Movement Measurements | 1 | 2012 | 35 | 0.110 |
Why?
|
| Home Nursing | 1 | 2013 | 92 | 0.110 |
Why?
|
| Discriminant Analysis | 1 | 2012 | 235 | 0.110 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2012 | 65 | 0.100 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2012 | 189 | 0.100 |
Why?
|
| Australia | 1 | 2014 | 1170 | 0.090 |
Why?
|
| Monitoring, Ambulatory | 1 | 2013 | 355 | 0.090 |
Why?
|
| Meta-Analysis as Topic | 1 | 2014 | 1344 | 0.080 |
Why?
|
| Lighting | 1 | 2010 | 231 | 0.080 |
Why?
|
| Sleep Stages | 1 | 2012 | 686 | 0.080 |
Why?
|
| North America | 1 | 2011 | 1249 | 0.080 |
Why?
|
| Focus Groups | 1 | 2012 | 1321 | 0.080 |
Why?
|
| Light | 2 | 2010 | 1374 | 0.080 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 780 | 0.080 |
Why?
|
| Young Adult | 6 | 2015 | 56430 | 0.070 |
Why?
|
| Occupations | 1 | 2009 | 517 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2023 | 4644 | 0.070 |
Why?
|
| Time Factors | 4 | 2012 | 40075 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2010 | 12026 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2029 | 0.060 |
Why?
|
| Appointments and Schedules | 1 | 2009 | 417 | 0.060 |
Why?
|
| Dangerous Behavior | 1 | 2005 | 66 | 0.060 |
Why?
|
| Arousal | 1 | 2010 | 1165 | 0.060 |
Why?
|
| Self Report | 2 | 2014 | 3558 | 0.060 |
Why?
|
| Adult | 9 | 2023 | 214055 | 0.060 |
Why?
|
| Reaction Time | 1 | 2010 | 2097 | 0.060 |
Why?
|
| Telemedicine | 1 | 2021 | 2872 | 0.060 |
Why?
|
| Reference Values | 1 | 2010 | 4982 | 0.060 |
Why?
|
| Nurses | 1 | 2012 | 2461 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4933 | 0.050 |
Why?
|
| Risk Factors | 4 | 2021 | 72290 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2010 | 1901 | 0.050 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3610 | 0.050 |
Why?
|
| Male | 10 | 2023 | 350118 | 0.050 |
Why?
|
| Humans | 16 | 2023 | 744343 | 0.050 |
Why?
|
| Middle Aged | 7 | 2021 | 213383 | 0.050 |
Why?
|
| Female | 10 | 2023 | 380194 | 0.050 |
Why?
|
| Attention | 1 | 2010 | 2400 | 0.050 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 1813 | 0.040 |
Why?
|
| Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
| Risk-Taking | 1 | 2005 | 986 | 0.040 |
Why?
|
| Comorbidity | 1 | 2011 | 10388 | 0.040 |
Why?
|
| Adolescent | 4 | 2015 | 85781 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15076 | 0.040 |
Why?
|
| Independent Living | 1 | 2021 | 568 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2013 | 25043 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2021 | 53288 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2013 | 264 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2023 | 2838 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2023 | 63114 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1590 | 0.020 |
Why?
|
| Rod Opsins | 1 | 2010 | 111 | 0.020 |
Why?
|
| Photoperiod | 1 | 2010 | 136 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2010 | 23338 | 0.020 |
Why?
|
| Laboratories | 1 | 2013 | 463 | 0.020 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2010 | 177 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2010 | 876 | 0.020 |
Why?
|
| Internet | 1 | 2021 | 3064 | 0.020 |
Why?
|
| Aged | 3 | 2021 | 163280 | 0.020 |
Why?
|
| Phototherapy | 1 | 2010 | 377 | 0.020 |
Why?
|
| Mental Health | 1 | 2021 | 3019 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2013 | 1738 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 3527 | 0.020 |
Why?
|
| Equipment Design | 1 | 2013 | 3582 | 0.020 |
Why?
|
| Retinal Ganglion Cells | 1 | 2010 | 770 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 2616 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 14722 | 0.010 |
Why?
|
| Health Personnel | 1 | 2009 | 3218 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15540 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 57776 | 0.010 |
Why?
|